ad-o53.2—a novel recombinant fusion protein combining the activities of trailapo2l and smacdiablo, overcomes resistance of human cancer cells to trailapo2l
本文档由 mom044406 分享于2017-01-22 02:35
ad-o53.2—a novel recombinant fusion protein combining the activities of trailapo2l and smacdiablo, overcomes resistance of human cancer cells to trailapo2l
下载文档
收藏
打印
分享:
君,已阅读到文档的结尾了呢~~